Efficacy, durability, and safety of faricimab in patients from Asian countries with neovascular age-related macular degeneration: 1-Year subgroup analysis of the TENAYA and LUCERNE trials.
Graefes Arch Clin Exp Ophthalmol
; 261(11): 3125-3137, 2023 Nov.
Article
em En
| MEDLINE
| ID: mdl-37294433
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Prognostic_studies
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article